Heron Therapeutics reported $-61015000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Amarin AMRN:US $ -12.97M 21.83M
Anika Therapeutics ANIK:US $ 1.25M 7.88M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Eisai 4523:JP Y 5564M 50219M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Immunogen IMGN:US $ -37.34M 6.6M
Insmed INSM:US $ -115292000 1.41M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Omeros OMER:US $ -22703000 5.89M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Surmodics SRDX:US $ -2.43M 0.94M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Veracyte VCYT:US $ -15.48M 24.67M
Zogenix ZGNX:US $ -58M 0.89M